We are live on ! Find out more
Mercer Global Advisors

Mercer Global Advisors Portfolio holdings

AUM $67.6B
1-Year Est. Return 18.3%
This Fund
S&P 500
This Quarter Est. Return
+5.33%
1 Year Est. Return
+18.3%
3 Year Est. Return
+51.43%
5 Year Est. Return
+55.53%
10 Year Est. Return
AUM
$42.7B
AUM Growth
+$6.05B
Cap. Flow
+$4.34B
Cap. Flow %
10.16%
Top 10 Hldgs %
37.29%
Holding
2,076
New
108
Increased
1,013
Reduced
740
Closed
124

Top Sells

Rank Stock Value
1
ASML icon
ASML
ASML
+$775M
2
AVGO icon
Broadcom
AVGO
+$334M
3
ADBE icon
Adobe
ADBE
+$268M
4
T icon
AT&T
T
+$230M
5
QUAL icon
iShares MSCI USA Quality Factor ETF
QUAL
+$96.5M

Sector Composition

Rank Sector Weight
1 Technology 6.54%
2 Healthcare 4.15%
3 Financials 3.22%
4 Industrials 2.54%
5 Consumer Staples 2.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CADE
1901
DELISTED
Cadence Bank
CADE
$66.7K ﹤0.01%
66,716
+2,542
+4% +$78.7K
ENIC icon
1902
Enel Chile
ENIC
$6.14B
$65.5K ﹤0.01%
23,631
-4,741
-17% -$13.1K
IGR
1903
CBRE Global Real Estate Income Fund
IGR
$709M
$64.6K ﹤0.01%
10,033
IRWD icon
1904
Ironwood Pharmaceuticals
IRWD
$696M
$61.6K ﹤0.01%
15,316
-1,287
-8% -$6.92K
TSE
1905
DELISTED
Trinseo
TSE
$59.8K ﹤0.01%
10,485
-191
-2% -$636
LWLG icon
1906
Lightwave Logic
LWLG
$995M
$59.3K ﹤0.01%
22,203
MIN
1907
Aberdeen Intermediate Income Fund
MIN
$274M
$58.5K ﹤0.01%
21,188
FTCI icon
1908
FTC Solar
FTCI
$44M
$58.2K ﹤0.01%
9,912
YALA
1909
Yalla Group
YALA
$818M
$55.7K ﹤0.01%
12,243
-622
-5% -$2.6K
RVNC
1910
DELISTED
Revance Therapeutics, Inc.
RVNC
$53.4K ﹤0.01%
10,278
-8,022
-44% -$39.9K
LQDB icon
1911
iShares BBB Rated Corporate Bond ETF
LQDB
$59.3M
$53.4K ﹤0.01%
53,424
ABEV icon
1912
Ambev
ABEV
$48.1B
$52.6K ﹤0.01%
+21,052
New +$47.2K
AKBA icon
1913
Akebia Therapeutics
AKBA
$354M
$49.6K ﹤0.01%
38,721
+7,500
+24% +$10K
SPWR icon
1914
SunPower Inc
SPWR
$60.6M
$49.1K ﹤0.01%
20,000
CIG.C icon
1915
CEMIG Ordinary Shares
CIG.C
$9.18B
$48.8K ﹤0.01%
18,760
+3,851
+26% +$9.29K
SOUN icon
1916
SoundHound AI
SOUN
$2.67B
$47K ﹤0.01%
+10,286
New +$49.7K
PTON icon
1917
Peloton Interactive
PTON
$2.77B
$46.6K ﹤0.01%
10,702
+2,664
+33% +$10.5K
OCC icon
1918
Optical Cable Corp
OCC
$131M
$45.9K ﹤0.01%
18,000
PDSB icon
1919
PDS Biotechnology
PDSB
$38.4M
$45.6K ﹤0.01%
12,500
CTOS icon
1920
Custom Truck One Source
CTOS
$2.31B
$42.8K ﹤0.01%
13,000
LPL icon
1921
LG Display
LPL
$3B
$42.6K ﹤0.01%
+10,627
New +$44K
ELDN icon
1922
Eledon Pharmaceuticals
ELDN
$261M
$40.8K ﹤0.01%
16,726
AAAU icon
1923
Goldman Sachs Physical Gold ETF Shares
AAAU
$2.46B
$40K ﹤0.01%
39,971
BZUN
1924
Baozun
BZUN
$167M
$38.5K ﹤0.01%
10,536
+430
+4% +$1.06K
BNKK
1925
Bonk Inc
BNKK
$7.25M
$37.2K ﹤0.01%
917

Similar funds

Mercer Global Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Mercer Global Advisors held 2,076 positions worth $42.7B, up 16% from $36.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Mercer Global Advisors deployed $4.34B of net new capital in Q3 2024, opening 108 new positions and adding to 1,013 existing holdings. Its largest new stake was Franklin Bitcoin ETF: 122,278 shares worth $4.76M.

By sector, the portfolio is most concentrated in Technology at 6.5% of assets, down from 7.3% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was ASML, an estimated $775M trimmed.

  • Mercer Global Advisors's largest Q3 2024 buy was Franklin Bitcoin ETF: 122,278 shares worth $4.76M.
  • Mercer Global Advisors added most to iShares Semiconductor ETF in Q3 2024, an estimated $1.67B increase.
  • Mercer Global Advisors's biggest Q3 2024 reduction was ASML, cutting an estimated $775M.
  • Mercer Global Advisors fully exited Lam Research in Q3 2024, selling an estimated $47.9M.
  • Mercer Global Advisors's ten largest holdings make up 37% of its $42.7B portfolio in Q3 2024.
  • Mercer Global Advisors opened 108 new positions and closed 124 in Q3 2024.
  • Mercer Global Advisors's portfolio value rose 16% quarter-over-quarter to $42.7B.

Based on Mercer Global Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.